Evidence map›Paper›PMID 32075595›Full record

ArticleBMC cancer2020

Rectal aberrant crypt foci (ACF) as a predictor of benign and malignant neoplastic lesions in the large intestine.

Marek Kowalczyk, Marcin Orłowski, Łukasz Klepacki, Krzysztof Zinkiewicz, Waldemar Kurpiewski, Dorota Kaczerska, Wiesław Pesta, Ewa Zieliński, Piotr Siermontowski

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Safety assessment of titanium dioxide (E171) as a food additive.EFSA journal. European Food Safety Authority · 2021
    Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Marek KowalczykDepartment of Oncologic and General Surgery, University Hospital in Olsztyn, Olsztyn, Poland.
Marcin OrłowskiCentre for Diagnosis and Treatment of Gastrointestinal Diseases, Gdańsk, Poland.
Łukasz KlepackiDepartment of Anatomy, University Hospital in Olsztyn, Olsztyn, Poland.
Krzysztof Zinkiewicz52nd Department of General, Gastroenterologic and Gastrointestinal Oncologic Surgery, Medical University of Lublin, University Hospital No.1, Lublin, Poland.
Waldemar KurpiewskiDepartment of Oncologic and General Surgery, University Hospital in Olsztyn, Olsztyn, Poland.
Dorota KaczerskaWSB University of Gdańsk, Gdańsk, Poland.
Wiesław PestaDepartment of Oncologic and General Surgery, University Hospital in Olsztyn, Olsztyn, Poland.
Ewa ZielińskiDepartment of Emergency Medicine and Disaster Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Toruń, Poland. ewa.zielinski.bydgoszcz@wp.pl.ORCID http://orcid.org/0000-0002-0013-6448
Piotr SiermontowskiDepartment of Underwater Works Technology, Polish Naval Academy, Gdynia, Poland.
Uniwersytecki Szpital Kliniczny w Olsztynie · PLMedical University of Lublin · PLNational Academy of Medicine · USNicolaus Copernicus University · PLUniversity of Gdańsk · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe importance of ACF is not fully explained, however, their number may be a good predictor of synchronous and metachronic adenoma or other polyps whose removal reduces the risk of CRC. Due to the epidemiological and genetic association of ACF with pre-cancer lesions, they may be a potential CRC biomarker. The aim of our study was to show that the number and type of rectal ACF may be a good predictive factor for the presence of polyps located proximally from the splenic flexure and that the type and number of ACF can correlate with the number and specific types of polyps in the large intestine.

methodsThe study included 131 patients who underwent colonoscopy combined with rectal mucosa staining with 0.25% methylene blue. The number of rectal ACF was determined and bioptats were sampled for histopathological examination to assess the type of ACF. Endoscopic ACF assessment criteria given by L. Roncucci were used. The obtained material was subjected to statistical analysis using probability distribution, U-test, t-student test, and chi

resultsThe study population was divided into three subgroups according to the number of ACF observed, i.e. ACF < 5, 5-10 and > 10. ACF < 5 were found in 35 patients (29.41%), 5-10 ACF in 70 (58.82%) and ACF > 10 in 14 individuals (11.76%). The study revealed the presence of normal ACF (p = 0.49), hyperplastic ACF (p = 0.34), dysplastic ACF (p = 0.11), and mixed ACF (p = 0.06). A single type of ACF was most commonly observed (n = 88, p = 0.74). In the researched group a larger number of ACF is concurrent with adenomas and hyperplastic polyps. The number of ACF clearly correlates with the dysplasia advancement in the adenoma and the number of polyps found.

conclusionsRectal ACF are a useful marker for the presence of cancerous lesions in the proximal and distal sections of the large intestine.

Indexed as

Aberrant Crypt FociAdenomaAgedBiomarkers, TumorColonic PolypsColonoscopyColorectal NeoplasmsFemaleHumansIntestine, LargeMaleMiddle AgedPrecancerous ConditionsRisk FactorsBiomarkers, TumorBenign and malignant neoplastic lesionsLarge intestineRectal ACF

Identifiers

PMID32075595
PMCPMC7029492
OpenAlexW3007436972

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.